BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 25444549)

  • 1. Chemokines in tuberculosis: the good, the bad and the ugly.
    Monin L; Khader SA
    Semin Immunol; 2014 Dec; 26(6):552-8. PubMed ID: 25444549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal-activated invariant T cells do not exhibit significant lung recruitment and proliferation profiles in macaques in response to infection with Mycobacterium tuberculosis CDC1551.
    Bucsan AN; Rout N; Foreman TW; Khader SA; Rengarajan J; Kaushal D
    Tuberculosis (Edinb); 2019 May; 116S():S11-S18. PubMed ID: 31072689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro- and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesis.
    Etna MP; Giacomini E; Severa M; Coccia EM
    Semin Immunol; 2014 Dec; 26(6):543-51. PubMed ID: 25453229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-22: An Underestimated Player in Natural Resistance to Tuberculosis?
    Ronacher K; Sinha R; Cestari M
    Front Immunol; 2018; 9():2209. PubMed ID: 30319650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammasome genetics contributes to the development and control of active pulmonary tuberculosis.
    Souza de Lima D; Ogusku MM; Sadahiro A; Pontillo A
    Infect Genet Evol; 2016 Jul; 41():240-244. PubMed ID: 27101784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis.
    Hunter RL
    Tuberculosis (Edinb); 2016 Mar; 97():8-17. PubMed ID: 26980490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis.
    Dorhoi A; Kaufmann SH
    Semin Immunopathol; 2016 Mar; 38(2):153-66. PubMed ID: 26438324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous latency in a rabbit model of pulmonary tuberculosis.
    Subbian S; Tsenova L; O'Brien P; Yang G; Kushner NL; Parsons S; Peixoto B; Fallows D; Kaplan G
    Am J Pathol; 2012 Nov; 181(5):1711-24. PubMed ID: 22960076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines shape the immune responses to tuberculosis.
    Slight SR; Khader SA
    Cytokine Growth Factor Rev; 2013 Apr; 24(2):105-13. PubMed ID: 23168132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL17 Is Dispensable during Hypervirulent
    Choreño-Parra JA; Dunlap MD; Swanson R; Jiménez-Álvarez LA; Muñoz-Torrico M; Guzmán-Beltrán S; Zúñiga J; Khader SA
    Immunohorizons; 2021 Sep; 5(9):752-759. PubMed ID: 34561226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reaction-diffusion model to understand granulomas formation inside secondary lobule during tuberculosis infection.
    Català M; Prats C; López D; Cardona PJ; Alonso S
    PLoS One; 2020; 15(9):e0239289. PubMed ID: 32936814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers.
    Lyadova IV; Panteleev AV
    Mediators Inflamm; 2015; 2015():854507. PubMed ID: 26640327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression.
    Sallin MA; Kauffman KD; Riou C; Du Bruyn E; Foreman TW; Sakai S; Hoft SG; Myers TG; Gardina PJ; Sher A; Moore R; Wilder-Kofie T; Moore IN; Sette A; Lindestam Arlehamn CS; Wilkinson RJ; Barber DL
    Nat Microbiol; 2018 Nov; 3(11):1198-1205. PubMed ID: 30202016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Mouse Model of Latent Tuberculosis Infection to Study Intervention Strategies to Prevent Reactivation.
    Kupz A; Zedler U; Stäber M; Kaufmann SH
    PLoS One; 2016; 11(7):e0158849. PubMed ID: 27391012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Versatile myeloid cell subsets contribute to tuberculosis-associated inflammation.
    Dorhoi A; Kaufmann SH
    Eur J Immunol; 2015 Aug; 45(8):2191-202. PubMed ID: 26140356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR5⁺ T helper cells mediate protective immunity against tuberculosis.
    Slight SR; Rangel-Moreno J; Gopal R; Lin Y; Fallert Junecko BA; Mehra S; Selman M; Becerril-Villanueva E; Baquera-Heredia J; Pavon L; Kaushal D; Reinhart TA; Randall TD; Khader SA
    J Clin Invest; 2013 Feb; 123(2):712-26. PubMed ID: 23281399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on host adaptation in response to Mycobacterium tuberculosis: modulation of inflammation.
    Dorhoi A; Kaufmann SH
    Semin Immunol; 2014 Dec; 26(6):533-42. PubMed ID: 25453228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen Modulates the Effectiveness of Granuloma Mediated Host Response to Mycobacterium tuberculosis: A Multiscale Computational Biology Approach.
    Sershen CL; Plimpton SJ; May EE
    Front Cell Infect Microbiol; 2016; 6():6. PubMed ID: 26913242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage immunoregulatory pathways in tuberculosis.
    Rajaram MV; Ni B; Dodd CE; Schlesinger LS
    Semin Immunol; 2014 Dec; 26(6):471-85. PubMed ID: 25453226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.
    Ardain A; Domingo-Gonzalez R; Das S; Kazer SW; Howard NC; Singh A; Ahmed M; Nhamoyebonde S; Rangel-Moreno J; Ogongo P; Lu L; Ramsuran D; de la Luz Garcia-Hernandez M; K Ulland T; Darby M; Park E; Karim F; Melocchi L; Madansein R; Dullabh KJ; Dunlap M; Marin-Agudelo N; Ebihara T; Ndung'u T; Kaushal D; Pym AS; Kolls JK; Steyn A; Zúñiga J; Horsnell W; Yokoyama WM; Shalek AK; Kløverpris HN; Colonna M; Leslie A; Khader SA
    Nature; 2019 Jun; 570(7762):528-532. PubMed ID: 31168092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.